abagovomab 33
abciximab 31
abituzumab 17
abrilumab 18
actoxumab 28
adalimumab 9
aducanumab 11
afasevikumab 7
alacizumab_pegol 6
alemtuzumab 38
alirocumab 14
amatuximab 45
andecaliximab 25
anifrolumab 28
anrukinzumab 14
aprutumab 19
aprutumab_ixadotin 19
arcitumomab 17
ascrinvacumab 16
atezolizumab 10
atinumab 17
avelumab 16
basiliximab 36
bavituximab 31
begelomab 26
benralizumab 25
bevacizumab_beta 16
bezlotoxumab 28
bimagrumab 22
bleselumab 28
blinatumomab 33
blosozumab 33
bococizumab 31
brazikumab 17
brentuximab_vedotin 30
briakinumab 15
brodalumab 22
brolucizumab 20
brontictuzumab 29
burosumab 30
cabiralizumab 26
camrelizumab 14
canakinumab 19
cantuzumab_ravtansin 42
carlumab 21
carotuximab 9
cergutuzumab_amunaleukin2 34
cergutuzumab_amunaleukin 34
certolizumab_pegol 22
cetiximab 33
citatuzumab_bogatox 25
cixutumumab 40
clivatuzumab_tetraxetan 29
codrituzumab 26
conatumumab 21
concizumab 17
crenezumab 19
crizanlizumab 26
crotedumab 22
dacetuzumab 23
daclizumab 25
dalotuzumab 33
dapirolizumab_pegol 25
daratumumab 13
dectrekumab 9
demcizumab 32
denosumab 10
depatuxizumab 27
depatuxizumab_mafodotin 27
dezamizumab 24
dinutuximab 34
diridavumab 31
domagrozumab 11
drozitumab 18
duligotuzumab 20
durvalumab 13
dusigitumab 35
efalizumab 33
efungumab 21
eldelumab 17
elezanumab 34
elgemtumab 5
elotuzumab 16
emactuzumab 26
emapalumab 19
emibetuzumab 23
enavatuzumab 24
enfortumab_vedotin 12
enoblituzumab 18
enokizumab 32
enoticumab 21
ensituximab 33
eptinezumab 10
erenumab 28
etaracizumab 12
etrolizumab 24
evinacumab 17
evolocumab 24
farletuzumab 0
fasinumab 30
fezakinumab 27
fibatuzumab 19
ficlatuzumab 32
firivumab 31
flanvotumab 22
fletikumab 41
foralumab 15
foravirumab 15
fremanezumab 24
fresolimumab 19
fulranumab 16
futuximab 23
galcanezumab 18
ganitumab 30
gantenerumab 15
gemetuzumab 33
gemtuzumab2 32
gemtuzumab 19
gevokizumab 24
girentuximab 29
glembatumumab 26
glembatumumab_vedotin 26
guselkumab 32
ibalizumab 25
ibritumomab 36
icrucumab 15
idarucizumab 32
ifabotuzumab 19
imalumab 14
imgatuzumab 28
inclacumab 16
indatuximab_ravtansin 33
indusatumab 21
inebilizumab 25
intetumumab 13
iodine_girentuximab 23
ipilimumab 4
iratumumab 23
isatuximab 29
itolizumab 20
ixekizumab 27
labetuzumab_govitecan 26
lambrolizumab 31
lampalizumab 29
lanadelumab 19
landogrozumab 20
laprituximab 25
lebrikizumab 30
lendalizumab 34
lenzilumab 26
lifastuzumab_vedotin 16
ligelizumab 24
lilotomab 35
lirilumab 29
lodelcizumab 29
lokivetmab 12
lorvotuzumab_mertansin 18
lucatumumab 30
lumretuzumab 25
lupartumab 16
lutikizumab 12
margetuximab 32
milatuzumab 26
mirvetuximab 35
mirvetuximab_soravtansin 35
modotuximab 48
mogamulizumab 21
monalizumab 26
motavizumab 31
moxetumomab_pasudotox 14
namilumab 24
naratuximab 36
naratuximab_emtansin 36
narnatumab 16
navicixizumab2 31
navicixizumab 32
navivumab 21
necitumumab 23
nemolizumab 37
nesvacumab 16
nivolumab 17
obiltoxaximab 20
obinutuzumab 34
ocaratuzumab 25
ofatumumab 14
olaratumab 25
olokizumab 21
omalizumab 20
onartuzumab 24
ontuxizumab 19
opicinumab 15
orticumab 10
otelixizumab 27
oxelumab 8
ozanezumab 24
pamrevlumab 7
panobacumab 23
parsatuzumab 29
pasotuxizumab 18
pateclizumab 17
patritumab 31
pembrolizumab 31
perakizumab 20
pidilizumab 19
pinatuzumab_vedotin 17
plozalizumab 13
pogalizumab 31
polatuzumab_vedotin 19
ponezumab 34
prezalumab 14
pritoxaximab 35
quilizumab 16
racotumomab 30
radretumab 11
ralpancizumab 34
ramucirumab 13
ranevetmab 29
ranibizumab 13
refanezumab 18
remtolumab 10
rilotumumab 28
rinucumab 20
risankizumab 37
rituximab 23
rivabazumab 23
robatumumab 19
roledumab 17
romosozumab 25
rontalizumab 26
rosmantuzumab 26
rozanolixizumab 18
sacituzumab 34
sacituzumab_govitecan 34
samalizumab 30
sapelizumab 23
sarilumab 10
secukinumab 19
seribantumab 19
setoxaximab 39
sifalimumab 18
siltuximab 12
simtuzumab 34
sirukumab 10
solanezumab 30
solitomab 27
stamulumab 28
suptavumab 25
suvizumab 23
tabalumab 17
tadocizumab 24
tamtuvetmab 32
tanezumab 26
tarextumab 10
tavolixizumab 14
telisotuzumab 31
teplizumab 20
tesidolumab 31
tezepelumab 29
tigatuzumab 13
tildrakizumab 25
timolumab 12
tisotumab 12
tosatoxumab 33
tositumomab 33
tralokinumab 34
trastuzumab 26
tregalizumab 19
trevogrumab 8
ublituximab 35
urelumab 29
ustekinumab 28
utomilumab 28
vadastuximab 24
vadastuximab_talirin 24
vandortuzumab_vedotin 21
vantictumab 25
vanucizumab2 16
vanucizumab 32
varlilumab 18
vatelizumab 25
vedolizumab 24
veltuzumab 27
vesencumab 10
vorsetuzumab 29
vorsetuzumab_mafodotin 29
vunakizumab 33
xentuzumab 18
zatuximab 48
